Metraipolis › archive › dc_d8d2ccdb88e5
Reversing chemoresistance in ovarian cancer: network pharmacology reveals how hydroxychloroquine/sulfasalazine duotherapy remodels tumor inflammatory-immune… — Europe PMC PMID:41972182
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41972182
- DOI
- 10.3389/fimmu.2026.1790210
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-03T21:02:15.613Z
- SHA-256 of the archived text
27667f7b917f24a899219bce56260debe6b1ff0e06e3efa62e56455eb1b2b528- Stable URL of this page
https://metraipolis.com/documento/dc_d8d2ccdb88e5
How to cite
Reversing chemoresistance in ovarian cancer: network pharmacology reveals how hydroxychloroquine/sulfasalazine duotherapy remodels tumor inflammatory-immune… — Europe PMC PMID:41972182 — Europe PMC (en), https://europepmc.org/article/MED/41972182 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_d8d2ccdb88e5 (Metraipolis archive dc_d8d2ccdb88e5, sha256 27667f7b917f24a899219bce56260debe6b1ff0e06e3efa62e56455eb1b2b528)
BibTeX
@misc{dcd8d2ccdb88e5,
title = {Reversing chemoresistance in ovarian cancer: network pharmacology reveals how hydroxychloroquine/sulfasalazine duotherapy remodels tumor inflammatory-immune… — Europe PMC PMID:41972182},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41972182},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_d8d2ccdb88e5; sha256 27667f7b917f24a899219bce56260debe6b1ff0e06e3efa62e56455eb1b2b528},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41972182. Agents can read the archived copy with the MCP tool read_document.